During the past decade, Praxis Dr. Beretta conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Praxis Dr. Beretta" are "Breast Cancer" (2 trials), "Colorectal Cancer" (1 trials), "Leukemia" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Praxis Dr. Beretta" in a lesser frequency.

Most popular intervention types in "Praxis Dr. Beretta" are "Drug" (5 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials), "prednisone" (2 trials), "rituximab" (2 trials) and "vincristine sulfate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Praxis Dr. Beretta" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Praxis Dr. Beretta". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Praxis Dr. Beretta, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Praxis Dr. Beretta, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".